|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/337 | |
| A61K 31/28 | |||
| A61K 45/06 | |||
| A61K 31/555 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2859916 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14192420.9 |
| Europos patento paraiškos padavimo data | 2009-05-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-11-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 55418 P | 2008-05-22 | US |
| (72) |
Keene, Jeffery, L., US
Riley, Dennis, P., US
Beardsley, Robert, A., US
|
| (73) |
Galera Labs, LLC,
1100 Corporate Square Drive, Suite 223, Creve Coeur, Missouri 63132,
US
|
| (54) | Combination of an antimitotic agent and a selective superoxide dismutase mimetic in antitumor therapy |
| Combination of an antimitotic agent and a selective superoxide dismutase mimetic in antitumor therapy |